|
Host: Bevin Amira, Deputy Director, NaRCAD
A conversation with Jerry Avorn, MD, Co-Founder and Special Adviser, NaRCAD Tag: Podcast Series, Evidence Based Medicine
How do we stay the course and stay rooted in facts amidst a major disruption impacting the healthcare landscape?
"Godfather" and originator of academic detailing Jerry Avorn joins the show to share his reflections on the current state of healthcare; the history of treatment and medications prior to rigorous study; his new book, Rethinking Medications; the critical importance of treating evidence, facts, and science as our collective North Star; and where we can look to a future where there is hope of correcting our course back towards the kind of evidence-based clinical care and health policy that we need, now more than ever! Visit rethinkmeds.info to connect with other Rethinking Medications readers, listeners, and thinkers, and check out the 2025 academic detailing systematic review mentioned in this episode, along with one from 2007. (Click here for the audio transcription.) 
"I'm hoping [...] that we will at some point, when we look back maybe a year from now, at the havoc that is being created on a daily basis in terms of our healthcare system, in terms of sowing doubt about treatments that work, about taking away coverage for things that are actually helping people, particularly disadvantaged populations." -Jerry Avorn, MD 
Jerry Avorn, MD (he/him)
Co-Founder & Special Adviser, NaRCAD Dr. Avorn is Professor of Medicine at Harvard Medical School and Chief Emeritus of the Division of Pharmacoepidemiology and Pharmacoeconomics (DoPE) at Brigham & Women's Hospital. A general internist, geriatrician, and drug epidemiologist, he pioneered the concept of academic detailing and is recognized internationally as a leading expert on this topic and on optimal medication use, particularly in the elderly. Read more. Want more? Follow us on Spotify or Apple!
0 Comments
Your comment will be posted after it is approved.
Leave a Reply. |
